health-it is the sole category represented across all 1 tracked stories. Schrödinger is most often covered alongside Churchill Downs Incorporated, which appears in 1 of these 1 story. Source depth averages 3 original sources per story, versus 4.7 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Schrödinger
health-it is the sole category represented across all 1 tracked stories. Schrödinger is most often covered alongside Churchill Downs Incorporated, which appears in 1 of these 1 story. Source depth averages 3 original sources per story, versus 4.7 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 5.6 in the same window. We currently track 1 Healthcare story that mention Schrödinger, all published on February 26, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 41 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Schrödinger. Shared-story counts are live from our verified record — not editorial picks.
GoodRx reported Q4 2025 sales that exceeded market expectations, yet shares fell nearly 12% as investors weighed future guidance and margin pressures. Meanwhile, Schrödinger is pivoting toward a hosted platform model, targeting 10-15% growth in annual contract value for its computational drug discovery suite.